Clincosm LogoSign in Get a demo

Colorectal Cancer

Showing NaN - NaN of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer Trial in Boston (LUM015, LUM 2.6 Imaging Device)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 15, 2022

Colorectal Cancer Trial in Worldwide (Regorafenib, Atezolizumab, Imprime PGG)

Recruiting
  • Colorectal Cancer
  • Duarte, California
  • +17 more
Aug 3, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Colorectal Cancer Trial in United States (Oral Tablet: Cabozantinib)

Completed
Has Results
  • Colorectal Cancer
  • Oral Tablet: Cabozantinib
  • Tucson, Arizona
  • +9 more
Jun 22, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Nivolumab
  • +3 more
  • Birmingham, Alabama
  • +101 more
Jun 13, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Reliability of the Shared Decision Making Process Survey

Completed
Has Results
  • High Cholesterol
  • +4 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 19, 2022

    Colorectal Cancer, Social Determinants of Health Trial in United States (Paired Screening Intervention)

    Completed
    • Colorectal Cancer
    • Social Determinants of Health
    • Paired Screening Intervention
    • Boston, Massachusetts
    • +3 more
    Apr 26, 2022

    Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)

    Completed
    Has Results
    • Colorectal Cancer
    • Birmingham, Alabama
    • +210 more
    Mar 30, 2022

    Colorectal Cancer Trial in Boston (Aspirin, Placebo)

    Recruiting
    • Colorectal Cancer
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Apr 5, 2022

    NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • N-803 + Pembrolizumab
    • +9 more
    • Anchorage, Alaska
    • +34 more
    Apr 4, 2022

    Solid Tumors, Colorectal Cancer, Breast Cancer Trial in Canada, United States (LY2880070, Gemcitabine)

    Completed
    • Solid Tumors
    • +11 more
    • Boston, Massachusetts
    • +8 more
    Mar 18, 2022

    Colorectal Cancer Trial in Canada, Puerto Rico, United States (celecoxib, 5-fluorouracil, )

    Active, not recruiting
    Has Results
    • Colorectal Cancer
    • Mobile, Alabama
    • +841 more
    Mar 18, 2022

    Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

    Recruiting
    • Non-small Cell Lung Carcinoma
    • +4 more
    • Boston, Massachusetts
    • +8 more
    Mar 18, 2022

    Colorectal Cancer Trial in Puerto Rico, United States (Colonoscopy, FIT)

    Active, not recruiting
    • Colorectal Cancer
    • Colonoscopy
    • FIT
    • Phoenix, Arizona
    • +45 more
    Mar 1, 2022

    Colorectal Cancer Trial in Worldwide (Nivolumab, Oxaliplatin, Leucovorin)

    Active, not recruiting
    Has Results
    • Colorectal Cancer
    • Nivolumab
    • +4 more
    • Birmingham, Alabama
    • +48 more
    Mar 2, 2022

    Prevention of Colorectal Cancer Through Multiomics Blood Testing

    Recruiting
    • Colon Cancer
    • +10 more
    • Freenome test
    • Anniston, Alabama
    • +173 more
    Mar 9, 2022

    Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

    Recruiting
    • Metastatic Cancer
    • +4 more
    • Phoenix, Arizona
    • +15 more
    Mar 9, 2022

    Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

    Terminated
    Has Results
    • Solid Tumor
    • +6 more
    • Birmingham, Alabama
    • +8 more
    Feb 16, 2022

    Breast Cancer, Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Worldwide (CB-103)

    Recruiting
    • Breast Cancer
    • +7 more
    • Santa Monica, California
    • +19 more
    Jan 6, 2022